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258 The Journal of Thoracic and Cardechnological advancements, such as the heart-lung machine, prosthetic
valves, intravascular catheters, and stents, have increased treatment options
for patients and have created exceptional growth for hospitals and cardiac
pecialists. Although cardiac surgeons have led much of this innovation, the deliv-
ry of these therapies has often been led by other medical specialties as the
rocedures have become less invasive (Table 1).
In 1990, coronary artery bypass grafting (CABG) and percutaneous coronary
nterventions were performed in approximately equal numbers. Since then, percu-
aneous coronary intervention volumes have grown considerably, whereas CABG
olumes have not (Figure 1).1 Although cardiac surgeons have adapted by focus
n surgical repair and replacement of valves, emerging technologies will 
urther changes.
There is a natural trend to decrease procedural invasiveness to mitigate risks and
ncrease acceptance. The ongoing efforts to treat many cardiovascular diseases less
nvasively include catheter-based approaches. In fact, catheter-based endoaortic
rafting and valve repair techniques are in clinical evaluation and might soon
ecome clinical realities. Cardiac surgeons should take a leading position in the
evelopment and delivery of these procedures.
merging Technologies Will Increase Procedural Demand
n the future, treatment options for patients with cardiovascular disease will include
pen surgical procedures, minimally invasive surgical intervention, and percutane-
us approaches (Figure 2). Patients contraindicated for surgical intervention m
e candidates for less-invasive treatments, and less recovery time and risk will
ncourage earlier intervention. Consequently, the number of patients treated will
ncrease.
The treatment of heart valve disease is one area affected by procedural evolution. For
nstance, only a small percentage of symptomatic patients with moderate-to-severe
itral regurgitation currently undergo a corrective procedure (Table 2).2-5 Although it i
ebatable whether earlier intervention would affect survival rates, it is reasonable to
ypothesize that decreasing mitral regurgitation and the volume load on the ventricle
ight affect quality of life. A similar argument can be made regarding patients with
ricuspid regurgitation, for whom treatment options can almost certainly be improved.
lthough the adverse effects of chronic volume loading on right ventricular perfor-
ance are poorly understood, it is worthwhile to consider the potential benefits of
ess-invasive procedures that would decrease the volume load.
Although most patients are treated for symptomatic and critical aortic stenosis,
ess-invasive procedures would be beneficial. In addition, intervention could be
xtended to patients for whom the risk of surgical intervention is currently prohib-
tive. Within the realm of heart valve disease, patients with pulmonic valve disease
re already benefiting from less-invasive approaches, in particular those patients
ith congenital heart disease. In terms of decreasing the number of reoperations, the
enefit to patients with pulmonic valve disease is very real.
Other growth opportunities exist beyond the treatment of heart valve disease. For
xample, less-invasive and catheter-based therapies are currently being investigated for
he treatment of aortic disease. Worthy of further investigation is ligation of the left atrial
ppendage for stroke prevention in patients with atrial fibrillation and patent foramen
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oL
c
t
w
r
t
r
t
C
S
F
w
H
u
p
T
A
a
S
2
U
o
T
U
M
A
T
S
†
e
c
p
i
f
o
p
p
Stuge and Liddicoat Editorials
ED
IT
O
RI
A
Lvale closure for patients with migraine headaches with aura.
ess-invasive approaches to each of these pathologies are
urrently in clinical trials.
The point of highlighting the aforementioned opportuni-
ies is not to state that all of these patients will be treated
ith new devices but rather to emphasize that many patients
emain underserved. Ultimately, the number of patients
reated will be determined by the relative patient benefit and
isk. By developing new skills, cardiac surgeons can meet
he needs of many of these patients.
ABLE 1. Less-invasive cardiovascular procedures
Aortic stent grafting
ASD/PFO closure
Mitral valvuloplasty for mitral stenosis
PDA closure
Alcohol septal ablation
Peripheral arterial stenting
Arterial endarterectomy-atherectomy
Catheter ablation accessory pathways and atrial fibrillation
Pericardial window
Portocaval shunting
Coronary artery balloon annuloplasty and stenting
SD, Atrial septal defect; PFO, patent foramen ovale; PDA, patent ductus
rteriosus.
ource: Medtronic, Inc. Interventions for heart valve disease by type,
003-2010. Cleveland, Ohio: Health Research International, Report #057-1-
S-0705-221, Summary Exhibit 2; 2005. p. ES-5. Reprinted with permission
f the publisher.Figure 1. Unbounded business for card
The Journal of Thoracicardiac Surgeons As Structural Heart Disease
pecialists: The New Paradigm
or the most part, the disease states that cardiac surgeons
ill treat in the future will remain the same as today.
owever, it might be useful to group these disease states
nder the heading of structural heart disease (SHD). This
rovides a framework for considering all of the conditions
ABLE 2. Estimated structural heart disease opportunity:
nited States
Patient population Currently treated
itral regurgitation
Moderate to severe 2,300,0002,3 48,000*2
Severe 220,0002,3
ortic stenosis
All grades 749,0002,4 79,0002
Severe 125,000†2,4,5
ricuspid regurgitation
Moderate to severe 1,600,000‡2,3 8000*2
uperscript numbers indicate references. *Includes repair and replacement.
Estimate published in the Health Research International Report 2005.2 The
stimate was derived from 2 sources. The first is an article from Stewart and
olleagues4 from the Cardiovascular Health Study. This article estimated the
revalence of aortic stenosis (by age) from a cohort of 5201. This prevalence
nformation was combined with data from Iivanainen and associates5 derived
rom the Helsinki Aging Study, which allowed an estimation of the percentage
f patients with aortic stenosis who have severe stenosis. ‡Estimated from the
revalence percentage cited in the article by Singh and coworkers3 times the
ercentage of the US population in the particular age group.iac providers: Historical profile.
and Cardiovascular Surgery ● Volume 132, Number 6 1259
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Lhat adversely affect the structure and function of the heart
nd thoracic aorta. Cardiac surgeons can therefore be con-
idered SHD specialists. In this article SHD includes con-
itions that affect the structure or function of the heart and
horacic aorta. By adopting a new treatment paradigm,
ardiac surgeons can maximize their opportunities within
he emerging discipline of SHD. As SHD specialists, car-
iac surgeons will offer patients a range of treatment op-
ions. Future cardiac surgeons will have a hybrid of cardiac
urgical and endovascular skills. This concept has already
een proved with thoracic aorta stent grafting. Trained
ardiac surgeons offer patients both surgical and catheter-
ased options. This model marks the beginning of an evo-
ution in cardiac surgery. r
260 The Journal of Thoracic and Cardiovascular Surgery ● DecAlthough most cardiac surgeons lack catheter therapy
xperience, demand is increasing for cardiac surgeons with
his expertise. A cardiac surgeon with catheter-based skills
s a valuable member of any team, representing the only
esource for surgical and catheter-based treatments. Further-
ore, cardiac surgeons are encouraged to adopt a multidis-
iplinary team approach, alleviating many “turf war” issues
nd improving patient care. A well-functioning multidisci-
linary team can provide a thorough evaluation and assess-
ent of treatment options.
Cardiac surgeons are in a unique position to lead the
ecision-making and treatment process for a number of
easons. First, cardiac surgeons are most familiar with the
Figure 2. Intervention for heart valve
disease: 2006-2010.elevant anatomy and pathophysiology. Second, cardiac sur-
ember 2006
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Leons can deliver the operations that will continue to be
mportant treatment options. Third, cardiac surgeons have
he available capacity to perform these procedures. Finally,
ardiac surgeons are best suited to handle complications
elated to these treatments.
ealizing the Opportunity
eveloping the requisite skills is a formidable challenge. Ad-
itional training must be addressed, however, to allow cardiac
urgeons to offer the full spectrum of therapies. Cardiac sur-
ery training programs are beginning to emphasize developing
ome of these skills, but the practicing physician will require a
ifferent path to acquire new skills. Therefore there is a need to
evelop a comprehensive, stepwise training program for prac-
icing cardiac surgeons interested in developing new skills
Table 3). This training program should be primarily instru
y physician peers and should include didactic, virtual, and
linical training. Furthermore, depending on the complexity of
he acquired skills, the surgeon in training must be supported
ith ongoing peer support in the clinical arena.
The daunting charge of additional training must be under-
aken by those committed to the future of cardiac surgery,
ABLE 3. Cardiovascular skills training
raining section Speci
ndovascular strategies General endovascular
Peripheral endovascul
eart valve surgery Advanced valve surge
inimally invasive cardiac surgery Advanced minimally in
Robotic cardiac surger
atheter-based valve therapies Aortic
Mitral
evascularization strategies Revascularization
Perfusion
ardiac surgery rhythm
management
Surgical ablation
Cardiac surgery pacing
eptal heart defect management ASD and PFO repair
ource: Medtronic, Inc. TECAB, total endoscopic coronary artery; ASD, ancluding cardiac surgeons, cardiac surgical societies, and in-
The Journal of Thoracicustry. These efforts will redefine the future of cardiac surgery
nd ensure the best possible treatment of patients with SHD.
onclusions
lthough initially posing a challenge to cardiac surgeons,
merging technologies also represent a significant opportu-
ity. Patients with structural heart disease will benefit from
ultiple treatment options offered by a multidisciplinary
eam that is led by uniquely skilled cardiac surgeons. Given
his new treatment paradigm, the future is promising for
oth cardiac surgeons and their patients.
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Targeted skill track
Basic endovascular skills
Abdominal aortic aneurysm repair
Thoracic aortic aneurysm repair
Peripheral endovascular techniques
Carotid angioplasty and distal protection
Complex mitral repair
Aortic root surgery
e valve surgery Aortic valve surgery
Mitral valve surgery
Mitral valve surgery
TECAB surgical techniques
Primary replacement
Redo prosthetic replacement
Annuloplasty
Edge-to-edge repair
Beating-heart surgery
Advanced arrested heart technologies
Expanding the scope of practice
Concomitant surgical ablation
Lone surgical ablation
Transvenous pacing techniques
Epicardial lead placement techniques
Percutaneous ASD and PFO repair
Congenital heart strategies
eptal defect; PFO, patent foramen ovale.alty
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